Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Liver Cirrhosis

Free Subscription 20.04.2026 1 Ann Intern Med 1 BMC Gastroenterol 1 Clin Res Hepatol Gastroenterol 5 Hepatology 1 J Gastroenterol Hepatol 1 J Hepatol 1 Lancet

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Intern Med

1. ROGAL S
   Inpatient Management of Patients With Cirrhosis.
   Ann Intern Med. 2026 Apr 14. doi: 10.7326/ANNALS-26-00513.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

2. SHERIEF DE, Shehata HH, Nosair N, Othman AAA, et al
   Systemic hematologic, metabolic, and inflammatory dysregulation in liver cirrhosis and hepatocellular carcinoma: diagnostic utility of novel indices in an Egyptian cohort.
   BMC Gastroenterol. 2026;26:229.
   PubMed         Abstract available
   
   

   
   Clin Res Hepatol Gastroenterol

3. ESPEROUZ F, Villani R, Ciavarella D, Serviddio G, et al
   How do oral pathogenic bacteria potentially contribute to inflammatory processes in autoimmune liver disease? Results from a systematic review.
   Clin Res Hepatol Gastroenterol. 2026;50:102797.
   PubMed         Abstract available
   
   

   
   Hepatology

4. GU H, Arab JP
   Beyond clinical comorbidities: Social determinants of health shape cirrhosis risk.
   Hepatology. 2026;83:1027-1028.
   PubMed        
   
   
5. BANSAL MB, Patton H, Morgan TR, Carr RM, et al
   Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance.
   Hepatology. 2025 Nov 7. doi: 10.1097/HEP.0000000000001608.
   PubMed         Abstract available
   
   
6. TELLEZ L, Toledano M, Alvarez M, Garrido-Lestache E, et al
   Distinctive hemodynamic phenotype in Fontan-type circulation patients with distal esophageal varices.
   Hepatology. 2025 Jul 22. doi: 10.1097/HEP.0000000000001472.
   PubMed         Abstract available
   
   
7. CHUNG BK, Jordens MS, Ogaard J, Reims HM, et al
   Multimodal transcriptomics identifies metallothionein as a novel pathway in primary sclerosing cholangitis.
   Hepatology. 2025 Jun 25. doi: 10.1097/HEP.0000000000001432.
   PubMed         Abstract available
   
   
8. LI J, Xu L, Rui F, Tran S, et al
   Type 2 Diabetes mellitus as an independent predictor of significant fibrosis in treatment-naive chronic hepatitis B patients with concurrent hepatic steatosis.
   Hepatology. 2025 Jun 25. doi: 10.1097/HEP.0000000000001442.
   PubMed         Abstract available
   
   

   
   J Gastroenterol Hepatol

9. GAO A, Luo J, Ye X, Hu Y, et al
   Comments on "Gut Microbiome Signatures Differ in Cirrhosis With and Without Hepatocellular Carcinoma in a Southeast Asian Cohort".
   J Gastroenterol Hepatol. 2026 Apr 17. doi: 10.1111/jgh.70395.
   PubMed        
   
   

   
   J Hepatol

10. KRAG A, Tacke F, Israelsen M, Younossi ZM, et al
    Is liver steatosis a disease or the emperor's new clothes?
    J Hepatol. 2026;84:993-1001.
    PubMed         Abstract available
    
    

    
    Lancet

11. GRAUPERA I, Thiele M, Castera L, Pera G, et al
    Prevalence of liver fibrosis in the general population (the LiverScreen project): a multinational European cohort study.
    Lancet. 2026;407:1448-1458.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum